EC Number |
Inhibitors |
Structure |
---|
3.2.2.6 | 1,N6-etheno NAD+ |
- |
|
3.2.2.6 | 1-[2-azido-2-deoxy-5-O-phosphono-D-threo-pentofuranosyl]-3-carbamoylpyridinium |
inhibition of the NADase activity |
|
3.2.2.6 | 1-[5-O-[(benzyloxy)(hydroxy)phosphoryl]-2-deoxy-2-fluoro-L-erythro-pentofuranosyl]-3-carbamoylpyridinium |
inhibition of the NADase activity |
|
3.2.2.6 | 1-[5-O-[butoxy(hydroxy)phosphoryl]-2-deoxy-2-fluoro-D-threo-pentofuranosyl]-3-carbamoylpyridinium |
inhibition of the NADase activity |
|
3.2.2.6 | 2'-deoxy-2'-beta-D-fluoroarabinofuranoside NAD+ |
- |
|
3.2.2.6 | 2'-deoxy-2'-beta-D-fluororibofuranoside NAD+ |
non-covalent complex of the inhibitor formed with enzyme mutant E218Q, PDB ID: 3ghh, and with wild-type enzyme, PDB ID: 3kou |
|
3.2.2.6 | 3-aminopyridine |
- |
|
3.2.2.6 | 3-carbamoyl-1-[2-chloro-2-deoxy-5-O-phosphono-D-threo-pentofuranosyl]pyridinium |
inhibition of the NADase activity |
|
3.2.2.6 | 3-carbamoyl-1-[2-deoxy-2-fluoro-5-O-phosphono-D-threo-pentofuranosyl]pyridinium |
inhibition of the NADase activity |
|
3.2.2.6 | 3-carbamoyl-1-[2-deoxy-2-fluoro-5-O-phosphono-L-threo-pentofuranosyl]pyridinium |
inhibition of the NADase activity |
|